STK11 and cancer: Functional scores—which were consistent with biochemical properties, smaller-scale assays, and pathogenicity annotations—identified a subset of PJS patients with germline STK11 variants diagnosed later in life, as well as somatic STK11 variants found in cancer patients that had comparable overall survival estimates to wild-type STK11.